Navigation Links
Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
Date:7/27/2010

CRANBURY, N.J., July 27 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) will release its second quarter 2010 financial results after the regular close of markets on Thursday, August 5, 2010. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m. EDT.

Interested participants and investors may access the conference call at 5 p.m. EDT by dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international). A telephonic replay of the call will be available for seven days beginning at 8 p.m. EDT. Access numbers for this replay are 800-642-1687 (U.S./Canada) and 706-645-9291 (international); participant code 87685684.

An audio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, an audio webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.

Amicus' press releases are available at

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
2. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
3. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
4. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
5. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
6. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
7. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
8. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
9. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
10. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... BURLINGTON, Mass. , Sept. 22, 2014 Decision ... Chilean pharmaceutical market is expected to be worth $2 billion ... 11.3 percent over the next five years (to 2018). This ... growth of 4.8 percent in 2013 and 4.9 percent expected ... pharmaceutical landscape is small but highly competitive. The ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... to their offering. On the ... technologies market has been divided into eight major ... hydrothermal, and hydromechanical ablation technologies. The light/laser ablation ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
(Date:9/23/2014)... Cubit Labs is pleased to announce ... Play Store. , The popular cross platform contact sharing ... this year, gleaning a solid 5 star rating in ... has never been so easy and I highly recommend ... steps." - CrackBerry.com, View full App review here: ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
(Date:9/23/2014)... by researchers from the University of Cambridge has found that ... childhood leaves a ,signature, in the brain. The results ... Cortex . , The researchers studied 80 adult men ... who did not. They found that language delay was associated ... regions, including the temporal lobe, insula, ventral basal ganglia, which ...
(Date:9/23/2014)... 2014 Névo takes a bold step ... and adding advanced activity tracking and phone notifications for ... distance, calories burned, and more. , http://www.nevowatch.com ... healthy habits in their busy lives to look and ... that produce healthy results, but until now, style played ...
(Date:9/23/2014)... Medicine in Motion (MIM) is proud to ... 711 W. 38th, Suite G4. After serving the area’s sports ... increased demand for MIM’s superior care led to the need ... extremely excited about bringing our high-quality brand of sports medicine ... in Motion. “We’ll continue to provide patients with the same ...
Breaking Medicine News(10 mins):Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2
... Creates New Opportunities for Expansion of HIFU Technology, ... (USHIFU), the,distributor and provider of non-invasive high intensity ... has completed the acquisition,of Focus Surgery, Inc. (FSI) ... Sonablate(R) 500, an image-guided acoustic ablation,device. This acquisition ...
... of today,s,announcement that Attorney General Mike Cox is filing ... Coalition for a Fair and,Competitive Insurance Market is calling ... Cross Blue Shield of Michigan (BCBSM) to use their,unfair ... insurance., "We were confident when we raised this ...
... 2 A Miami resident was,sentenced to 130 months ... the,Medicare program, Acting Assistant Attorney General Matthew Friedrich of,the ... the Southern,District of Florida announced today., Gustavo Smith, ... for,the Southern District of Florida by Judge Marcia G. ...
... could one day help tailor treatments to individual patients, study ... technique for finding and analyzing stray cancer cells in the ... doctors to one day not only determine the genetic "signature" ... and adjust treatments accordingly. , "I think this is ...
... QC, July 2 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... a complete response to,the Food and Drug Administration ... the FDA,s Deputy Director, Center for Drug Evaluation,and ... regulatory path towards,potential U.S. approval of the Company,s ...
... July 2, 2008 -- Compact, bedside brain-activity monitors ... Washington University School of Medicine in St. Louis ... clinicians in monitoring for electrical seizures until confirmation ... an article published in the June issue of ...
Cached Medicine News:Health News:USHIFU, LLC Completes Acquisition of Focus Surgery, Inc. 2Health News:Coalition Calls on MI Legislature to Abandon Blue Cross Legislation 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 2Health News:Owner of Medical Equipment Company Sentenced to 130 Months in Prison for Health Care Fraud 3Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 2Health News:Circulating Tumor Cells Reveal Insights Into Lung Cancers 3Health News:Labopharm Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 2Health News:Seizures in newborns can be detected with small, portable brain activity monitors 3
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... The 2201 is ideal for applications ... application of heat. , ,The autoclavable ... assortment of reusable thermal cautery electrodes, ... flexibility to perform a wide variety ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: